Skip to main content
fr
en
Toggle navigation
Main navigation
Company
Company profile
Management
Our history
Great Place to Work
Science
Scientific approach
Innate Immunity & NK cells
Antibody formats
ANKET®: Our NK cell engager Platform
Publications
Products
Pipeline overview
Clinical trials
------------------
Lacutamab
Monalizumab
IPH5201
IPH5301
IPH6101
IPH62
IPH6401
IPH6501
Partnering
Investors
Overview
News
Events
Stock Info
Financial and Regulatory Information
General Shareholders Meeting
Governance
Resources
Media
Media hub
All press releases
Media center
Careers
Home
Media
Media center
Nasdaq #BehindTheBell (October 17, 2019)
Nasdaq #BehindTheBell (October 17, 2019)
Wed, 10/30/2019 - 09:45
Category
Corporate
